MedTrace Logo

Single Superior ILM/ERM Flap for the FTMH.

NCT05494242 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2023-03-24

No results posted yet for this study

Summary

In this study, the investigators will make the only upper flap either from the internal limiting membrane or from the epiretinal membrane to cover the full thickness macular hole.

Conditions

  • Ophthalmopathy

Interventions

OTHER

Surgical intervention

Pars-plana vitrectomy.

Sponsors & Collaborators

  • Ibinsina Modern Eye and Retina Center

    collaborator OTHER

  • Omer Othman Abdullah

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2023-03-21
Completion
2023-03-21

Countries

  • Iraq

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05494242 on ClinicalTrials.gov